Is chemotherapy effective for advanced pancreatic cancer? There are certain indications

Is chemotherapy effective for pancreatic cancer in the late stage? Pancreatic cancer is a disease with very serious hazards. In the late stage, the symptoms will be more obvious and severe. The patient's body will become weaker and weaker and may die at any time. So is chemotherapy effective for pancreatic cancer in the late stage? Next, let's take a look together.

If a patient wants to undergo chemotherapy for pancreatic cancer, some analysis is needed because there are certain indications. Indications for chemotherapy for pancreatic cancer: patients with pancreatic cancer that cannot be surgically removed; patients with pancreatic cancer accompanied by obstructive jaundice; patients with recurrence of pancreatic cancer after surgical resection; patients with pancreatic cancer accompanied by distant metastasis or metastasis after surgery; arterial infusion chemotherapy to prevent recurrence of pancreatic cancer after surgery. Contraindications for chemotherapy for pancreatic cancer: patients with systemic failure and cachexia; severe liver and kidney dysfunction; severe coagulation dysfunction; large amounts of ascites.

Pancreatic cancer chemotherapy is usually taken orally or by injection. Some chemotherapy drugs are taken in tablet form, and the price of chemotherapy drugs varies. Others are injected into the muscle or subcutaneously, and some are injected into the spinal cavity (intrathecal injection). More commonly, they are injected into the vein.

Regarding the question of how long a patient can live with advanced pancreatic cancer, generally speaking, when the cancer has been diagnosed but has not metastasized, biological therapy used alone in clinical practice can accurately and systematically kill tumor cells; for patients who have already developed metastases, biological immunotherapy combined with radiotherapy and chemotherapy can completely eliminate residual cells, establish an immune barrier, and reduce the chance of metastasis and spread; for patients with severe conditions, unappreciated radiotherapy and chemotherapy, or who cannot withstand radiotherapy and chemotherapy, biological immunotherapy has no toxic side effects, can alleviate various pains, and ensure that advanced patients "live with tumors" for a long time.

From the above, we can see that patients with advanced pancreatic cancer can undergo appropriate chemotherapy according to the pharmacist's introduction. The survival time of different patients is different, and if they persist in treatment, their life span can be extended.